基于生物的技术,以实现高效和有针对性的RNA输送
Anastasiya Kostyusheva1, Sergey Brezgin2, Natalia Ponomareva2
1Laboratory of Genetic Technologies, Martsinovsky Institute of Medical Parasitology, Tropical and Vector-Borne Diseases, First Moscow State Medical University (Sechenov University), Moscow 119435, Russia.
概括
研究人员开发了混合纳米纤维 (Hybs) 进行高效的RNA输送,克服了当前RNA疗法的局限性. 这些新型输送载体在体外和体内表现出增强的细胞吸收和治疗潜力.
科学领域:
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
- 分子生物学分子生物学
背景情况:
- 对RNA疗法的日益增长的需求需要先进的输送系统.
- 目前的RNA输送方法面临安全性和效率方面的挑战.
- 细胞外囊泡模拟纳米囊泡 (EMNVs) 具有潜力,但需要改进准和内部化.
研究的目的:
- 开发新的混合纳米纤维 (Hybs) 来增强RNA传递.
- 通过使用截断的CD63或PTGFRN蛋白来设计具有组织向能力的EMNV.
- 评估发达的Hybs.的体外和体内效率和细胞命运.
主要方法:
- 混合EMNV-脂质体 (Hybs) 的制造.
- 用切断的CD63或PTGFRN对EMNV进行基因工程以定位.
- 纳米粒子内部化和RNA传递效率的体外和体外评估.
- 对EMNVs和Hybs.的溶酶体同位化和稳定性的比较分析.
- 产生具有小干扰RNA (siRNA) 的向肝脏的Hybs.
主要成果:
- 功能化的EMNV显示在体外增强了10倍以上,在体内增强了2倍以上的纳米粒子内部化.
- 在人类和小鼠细胞系中,Hybs实现了>85%的RNA传递效率.
- 与EMNV不同,Hybs在时间的推移中显示出溶酶体逃脱.
- 充满siRNA的向肝脏的Hybs在体外和体外表现出强大的治疗效率.
结论:
- 开发的混合纳米纤维 (Hybs) 是RNA传递技术的重大进步.
- 具有向蛋白质的工程 EMNV 增强细胞吸收和治疗疗效.
- Hybs为下一代RNA疗法提供了一个有前途的平台,具有更好的安全性和向性.
相关概念视频
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
RNA Interference
25.9K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.9K
Microorganisms in Medicine and Therapeutics
1
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1
Nucleic Acids
43.7K
Nucleic acids are the most important macromolecules for the continuity of life. They carry the cell's genetic blueprint and carry instructions for its functioning.
DNA and RNA
The two main types of nucleic acids are deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). DNA is the genetic material in all living organisms, ranging from single-celled bacteria to multicellular mammals. It is in the nucleus of eukaryotes and in the organelles, chloroplasts, and mitochondria. In prokaryotes,...
DNA and RNA
The two main types of nucleic acids are deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). DNA is the genetic material in all living organisms, ranging from single-celled bacteria to multicellular mammals. It is in the nucleus of eukaryotes and in the organelles, chloroplasts, and mitochondria. In prokaryotes,...
43.7K
siRNA - Small Interfering RNAs
16.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K


